OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2695-2709
Open Access | Times Cited: 143

Showing 26-50 of 143 citing articles:

Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13

Efficacy of dupilumab in real-life settings: a STROBE study
A. Gal, R. Gravier-Dumonceau, M. Pénicaud, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4781-4788
Closed Access | Times Cited: 5

Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis
Xiaoying Chen, Haopeng Zhi, Xiaohu Wang, et al.
Lung (2024) Vol. 202, Iss. 4, pp. 367-383
Closed Access | Times Cited: 5

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
Celeste M. Boesjes, Esmé Kamphuis, Marlies de Graaf, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 10, pp. 1044-1044
Closed Access | Times Cited: 5

Combination of Biological Therapy in Severe Asthma: Where We Are?
Lorenzo Carriera, Marta Fantò, Alessia Martini, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 12

Effect of dupilumab on sputum eosinophils in patients with moderate‐to‐severe asthma
Sarah Svenningsen, Melanie Kjarsgaard, Kayla Zhang, et al.
Allergy (2023) Vol. 79, Iss. 2, pp. 509-513
Closed Access | Times Cited: 11

Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience.
Gianluca Bellocchi, Antonella Loperfido, Francesco Maria Passàli, et al.
PubMed (2023) Vol. 94, Iss. 5, pp. e2023227-e2023227
Closed Access | Times Cited: 11

The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4

Postmarketing Analysis of Eosinophilic Adverse Reactions in the use of Biologic Therapies for Type 2 Inflammatory Conditions
Dafna Gershnabel Milk, Kent Lam, Joseph K. Han
American Journal of Rhinology and Allergy (2024)
Closed Access | Times Cited: 4

Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Andrea Ciofalo, Antonella Loperfido, Silvia Baroncelli, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Closed Access | Times Cited: 4

Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4

Single-cell RNA sequencing reveals transcriptional changes in circulating immune cells from patients with severe asthma induced by biologics
Kyungtaek Park, Ji‐Hyang Lee, Eun‐Soon Shin, et al.
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 4

Biologics in severe asthma: a state-of-the-art review
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
Daiki Nakashima, Tsuguhisa Nakayama, Shunsuke Minagawa, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100412-100412
Open Access

Eosinophilic Granulomatosis With Polyangiitis: A Real‐World Study of Biologics and Sinus Surgery Use for Managing Nasal Polyposis
Nitish Kumar, Savannah D. Jett, Pedro Lança Gomes, et al.
International Forum of Allergy & Rhinology (2025)
Closed Access

Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access

Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access

Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model
Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access

Heterogeneity and individualized therapy for eosinophilic granulomatosis with polyangiitis
Lijuan Hua, Min Xie
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access

Levée de la PIH, qui, quand, comment prescrire les biothérapies dans l’eczéma atopique
C. Jaulent-Darmaisin
Revue française d'allergologie (2025) Vol. 65, pp. 104240-104240
Closed Access

Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region
Qingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Clinical & Experimental Allergy (2025)
Open Access

Genetic and Epigenetic Interconnections Between Atopic Dermatitis, Allergic Rhinitis, and Rhinitis with Nasal Polyps
Alexandra Danielidi, Spyridon Lygeros, A. Anastogianni, et al.
Allergies (2025) Vol. 5, Iss. 2, pp. 9-9
Open Access

Head‐To‐Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?
Brian J. Lipworth, Robert Greig, Rory Chan, et al.
Allergy (2025)
Open Access

Scroll to top